ESC 365 - hsCRP and Long-term CV Outcomes among SMuRF-Less Women

ESC2025 Premium Access

hsCRP and Long-term CV Outcomes among SMuRF-Less Women

Session: Late-Breaking Clinical Science: inflammation and immune biomarkers in cardiovascular risk prediction

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor P. Ridker (Boston, US)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Paul M Ridker

Brigham and Women's Hospital, Boston (United States of America)

42 presentations

9 followers

5 more presentations in this session

Interleukin-6 and cardiovascular prognosis in apparently healthy individuals

Speaker: Doctor B. Kurt (Aachen, DE)

Coronary and systemic inflammation: the ORFAN study

Speaker: Doctor K. Chan (Oxford, GB)

C-reactive protein and cardiovascular risk in the general population

Speaker: Professor F. Kahles (Aachen, DE)

THYM-AF Study: T-Cell Subsets and Atrial Fibrillation

LoDoCo2: Effect of Colchicine on Clonal Hematopoiesis and Inflammatory Biomarkers

Speaker: Mr N. Mohammadnia (Nijmegen, NL)

Access the full session

Late-Breaking Clinical Science: inflammation and immune biomarkers in cardiovascular risk prediction

Speakers: Doctor P. Ridker, Doctor B. Kurt, Doctor K. Chan, Professor F. Kahles, Mr N. Mohammadnia

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources